The team revolutionising cancer management
The Resitu Medical core team has more than 100 years of combined experience in life science and the medical device sector.
To get in contact with Resitu Medical: Visit the contact page.
CEO
Stefan Sowa, MSc, MBA
Stefan Sowa has worked in the Life Science industry since 1984. Twenty of these years has been devoted to Medical Devices, including ten years as production manager and six years as CEO in development, manufacturing and sales of surgical implants. Stefan has held positions as business development consultant, coach and board member.
CCO
Therese Sundell, MSc
Therese Sundell has over 20 years of experience of stategic and tactical marketing in the life science industry on a global level. She has built and headed marketing teams, developed new corporate identities and websites, conducted market research and organised and executed marketing activities.
CTO, Partner
Per Egnelöv
Per Egnelöv has over 30 years of experience in the medical device sector with emphasis on product development of Class 2 and 3 products. Per is a skilled medical device inventor and developer. He has long experience and technical expertise in development of prototypes and final construction of medical technical instruments.
External Collaborations Manager
Heather Marshall-Heyman, MSc, PhD
Heather Marshall-Heyman is an experienced project and programme manager within the life science sector. For the past 15 years, she has been working with strategic development of innovations within SMEs. She is an expert in strategic project and partnership development, science writing, innovation funding and international project collaboration.
CMO, Jenny Palming
Jenny Palming has worked with clinical studies within academia, healthcare and industry since 2008 and has managed a range of studies from smaller investigator-initiated studies to large multi-center industry sponsored studies.
Board Members
Pär Nordström, M Sc Chairman of the Board
Solid Venture Capital and board experience. Broad and extensive experience within international sales, marketing, management, advanced technology and medicine. Global business experiences. Experience from therapy within Cardiology, Neurosurgery, Radiotherapy and Oncology.
Per Hedén, MD, PhD, Inventor, founder. Ass prof. plastic surgery KI, co-founder Akademikliniken
Dr. Per Hedén is an Associate Professor of Plastic Surgery at Karolinska Institute in Stockholm. Sweden. He was the pioneer in establishing microsurgical procedures in the Stockholm region in the beginning of the 1980's and still has a profound interest in reconstructive surgery and a special interest in facial paralysis reanimations. Dr Hedén is the Founder of Akademikliniken, Europe’s largest private hospital exclusively for plastic surgery.
Håkan Sjunnesson, M Sc, founder
Investor, Chair of several growth companies including Paradox Interactive AB, Coolstuff AB, Qvalia Group AB, Emerse AB and Aktivbo Group AB. Member of the board in NuvoAir AB, Novoaim AB and Dalex AB. Previous assignments include Investment Manager Spiltan Invest AB, Managing Partner Nordic Countries Monitor Group, Vice President & Country Manager Gemini Consulting.
Gustav Notander, M Sc, ALMI Invest Stockholm
Gustav has a MSc.Eng. in Biotechnology from KTH Royal Institute of Technology in Stockholm. He is currently working as Investment Manager at Almi Invest Stockholm, and in addition to Resitu, is a member of the board in Developeration AB, and Medituner AB.
He has previously worked 15+ years as a business development coach and technology transfer manager at KTH Innovation, and as IP Manager at KTH Holding AB.
Claes Post, MSc, PhD Pharmacy, STOAF Invest Stockholm
Other Current assignments: General Partner STOAF III SCITECH, member of the Board of Vakona AB, Developeration AB, and STOAF III Venture Partners AB. Previous Adjunct Professor Uppsala University, Lund University and Karolinska Institute. Previous assignments include Vice President and Senior Vice President positions at Astra and Pharmacia, CEO and Board positions at many Life Science start-up companies, including Dicot AB, AroCell AB, and IDL Biotech AB. Also partner at Danske Life Science, venture partner HealthCap and Nordic Biotech, and Investment Manager at ALMI Invest.